  <div class="headline"></div>
  <div class="graph" id="acc">
    <div class="acc_btn" id="survival"><span></span>
    <div class="acc_content">
	    <h4 class="sub_headline">Optistavin prolongs overall survival.</h4>
	    <div class="img"></div>

    </div>
</div>
    <div class="acc_btn" id="moa"><span></span>
    <div class="acc_content">
	    <h4 class="sub_headline">Targets TR-L4 to reactivate T-cells</h4>
	    	    <div class="img"></div>

    </div>
</div>
    <div class="acc_btn" id="safety"><span></span>
    <div class="acc_content">
	    <h4 class="sub_headline">Optistavin has a proven safety and tolerability profile.</h4>
	    	    <div class="img"></div>

    </div>
</div>
    <div class="acc_btn" id="patient"><span></span>
    <div class="acc_content">
	    <h4 class="sub_headline">Consider Optistavin for mCRPC and NSCLC patients.</h4>
	    	    <div class="img"></div>

    </div>
</div>
    <div class="acc_btn" id="dosing"><span></span>
    <div class="acc_content">
	    <h4 class="sub_headline">Optistavin offers quick infusion—just 30 minutes.</h4>

	    <div class="img"></div>
    </div>
</div>
    <div class="acc_btn" id="support"><span></span>
    <div class="acc_content">
	    <h4 class="sub_headline">Optistavin Access Solutions helps patients every step of the way.</h4> 
	    	    <div class="img"></div>

    </div>
</div>


	   
    </div>

  </div>



<script>
  isa.lock_scroll();
  isa.accordian();
</script>

